Boston Scientific Corporation (BSX)

56,14 +0,25 (+0,45 %) À la clôture : 04:00PM EST

Boston Scientific Corporation

300 Boston Scientific Way
Marlborough, MA 01752-1234
United States
508 683 4000
https://www.bostonscientific.com

Secteur(s): Healthcare
Secteur d’activité: Medical Devices
Employés à temps plein: 45 000

Dirigeants clés

Nom	Titre	Payer	Exercé	Année de naissance
Mr. Michael F. Mahoney	Chairman, President & CEO	3,77M	15,78M	1965
Mr. Daniel J. Brennan	Executive VP & CFO	1,69M	1,96M	1966
Mr. Joseph M. Fitzgerald	Executive VP & Group President of Cardiology	1,53M	3,2M	1964
Mr. Jeffrey B. Mirviss	Executive VP & President of Peripheral Interventions	1,15M	977,61k	1966
Mr. Arthur Crosswell Butcher	Executive VP and Group President of MedSurg & Asia Pacific	1,4M	155,24k	1971
Mr. John Bradley Sorenson	Executive Vice President of Global Operations	S.O.	S.O.	1968
Mr. Jonathan R Monson	Senior VP, Global Controller & Chief Accounting Officer	S.O.	S.O.	S.O.
Ms. Jodi Euerle Eddy	Senior VP and Chief Information & Digital Officer	S.O.	S.O.	1973
Ms. Susan Vissers Lisa	Vice President of Investor Relations	S.O.	S.O.	1969
Mr. Vance R. Brown	Senior VP, General Counsel & Corporate Secretary	S.O.	S.O.	S.O.

Les montants ont été établis en date du 31 décembre 2022 et les valeurs de compensation concernent le dernier exercice fiscal clos à cette date. Le terme « rémunération » désigne le salaire, les bonus, etc. Le terme « exercé » est utilisé pour la valeur des options exercées au cours de l’exercice fiscal. Devise exprimée en USD.

Description

Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through MedSurg and Cardiovascular segments. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various urological and pelvic conditions; implantable cardioverter and implantable cardiac resynchronization therapy defibrillators; pacemakers and implantable cardiac resynchronization therapy pacemakers; and remote patient management systems. It also provides medical technologies to diagnose and treat rate and rhythm disorders of the heart comprising 3-D cardiac mapping and navigation solutions, ablation catheters, diagnostic catheters, mapping catheters, intracardiac ultrasound catheters, delivery sheaths, and other accessories; spinal cord stimulator systems for the management of chronic pain; indirect decompression systems; and deep brain stimulation systems. In addition, the company offers interventional cardiology products, that uses in the treatment of coronary artery disease and aortic valve conditions. Further, it provides stents, balloon catheters, guidewires, atherectomy, and thrombectomy systems to treat arterial and venous diseases; and peripheral embolization devices, radioactive microspheres, cryotherapy ablation systems, and micro and drainage catheters to treat cancer. The company was incorporated in 1979 and is headquartered in Marlborough, Massachusetts.

Gouvernance d’entreprise

L’ISS Governance QualityScore de Boston Scientific Corporation en date du 1 décembre 2023 est 9. Les scores principaux sont Audit : 10; Société : 9; Droits des actionnaires : 8; Compensation : 7.

Résultats de gouvernance d’entreprise offerts par Institutional Shareholder Services (ISS). Les résultats indiquent un rang décile par rapport à l’indice ou à la région. Un résultat décile de 1 indique un risque de gouvernance faible, tandis que 10 indique un risque de gouvernance élevé.